CAPR•benzinga•
FDA Completes Pre-License Inspection Of Capricor Therapeutics' San Diego Manufacturing Facility For Deramiocel; Company Expects Facility Will Meet All Requirements To Support Licensure
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 11, 2025 by benzinga